home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

European Stem Cells & Regenerative Medicine Congress 2007

 
  January 12, 2007  
     
 


Terrapinn Ltd, The Landmark London Hotel
01-03 May 2007


Confirmed conference topics for the European Stem Cell & Regenerative Medicine Congress 2007 include:

Stem cells in drug discovery and development
Target identification and validation
Lead identification and optimisation
High through-put drug screening
Drug safety applications
Laying foundations for stem cell funding
Translational stem cell science – a roadmap to the clinic
Stem cell commercialisation - turning science into business
Negotiating the obstacles to clinical trial
Assessment of therapeutic potential
Core development and manufacturing expertise

http://www.lifescienceworld.com/2007/stemcells/confprog.stm

 
 
Organized by: Terrapinn Ltd
Invited Speakers: Speakers and their application at a glance

Pharmaceutical
Dr Ruth McKernan, Vice President, and Head of Discovery Biology, Pfizer Global Research and Development
Professor Ian Cotgreave, Director of Molecular Toxicology, Safety Assessment, AstraZeneca
Dr Christophe Labie, Group Leader, CNS Department, sanofi-aventis
Dr Ignacio Munoz-Sanjuan, Senior Scientist, Amgen

Biotechnical
Hugh Ilyine, Vice President and Chief Operating Officer, Stem Cell Sciences
Christopher J Calhoun, Chief Executive Officer, Cytori Therapeutics
Michael Hunt, Chief Executive Officer, ReNeuron
Dr Thomas B Okarma, President and Chief Executive Officer, Geron
Dr Michael West, President and Chief Scientific Officer, Advanced Cell Technology
Dr John Sinden, Chief Scientific Officer, ReNeuron
Dr Tim Allsopp, Chief Scientific Officer, Stem Cell Sciences
Dr Mike Leek, Vice President – Operations, Intercytex
Dr Geoff MacKay, President and Chief Executive Officer, Organogenesis
Michael Siani-Rose, President and Founder, Theregen Corporation
Professor Eldad Melamed, Chief Medical Advisor, Brainstorm Cell Therapeutics
Dr Holly Atkinson, Director of Business Development, Brainstorm Cell Therapeutics
Dr Alan Lewis, President and Chief Executive Officer, Novocell
George W Dunbar, President and Chief Executive Officer, Aastrom Biosciences
Dr David Eisenbud, Executive Vice President and Chief Medical Officer, Advanced BioHealing
Dr Lilian Wikström, Head of Research, NeuroNova
Bruce Cohen, President and Chief Executive Officer, Cellerant Therapeutics
Dr Jon Tinsley, Head of Biology, VASTox
Dr Yen Choo, Founder and Chief Executive Officer, Plasticell
Dr Lauren E Black, Senior Scientific Advisor, Navigators, Preclinical Services, Charles River Laboratories
Dr Jon Chesnut, Research and Development Manager, Invitrogen
Dr Helmuth van Es, Chief Scientific Officer, Stem Cell Innovations
Professor Lars E Sundstrom, Chief Scientific Officer, Capsant Neurotechnologies
Dr Paul Rounding, Managing Director, Business Development & Operations, Artemis Pharmaceuticals
Dr Paul Rodgers, Founder and Managing Director, Ithaka LifeSciences

Academic / Clinical
Dr Chris Mason, Director, Regenerative Medicine Bioprocessing Unit, University College London
Dr Stephen L Minger, Director, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, King’s College London
Professor Peter W Andrews, Professor of Biomedical Science, Department of Biomedical Science, University of Sheffield
Dr Gabriela Gebrin Cezar, Assistant Professor, Department of Animal Science, University of Wisconsin-Madison
Professor Oliver Brüstle, Director, Institute of Reconstructive Neurobiology, University of Bonn and Scientific Director, LIFE & BRAIN
Professor Yann Barrandon, Joint Chair of Stem Cell Dynamics, Centre Hospitalier Universitaire Vaudois (CHUV) and Ecole Polytechnique Fédérale de Lausanne (EPFL)
Dr Jan Matthias Braun, Coordinator, Regenerative Medicine Network, Leipzig-Halle Max Buerger Research Centre, University of Leipzig
Government / Regulatory
Dr Octavi Quintana Trias, Director “Health”, Research DG, European Commission
Dr Mark Bale, Head of Genetics Branch, Scientific Development & Bioethics Division, Department of Health, UK
David Macauley, Chief Executive, UK Stem Cell Foundation
Dr Frances Rawle, Programme Manager, Molecular and Cellular Medicine Board, Medical Research Council
Dr Colin Miles, Head, Molecular & Cell Biology Branch, Science & Technology Group, BBSRC
Dr Mark Walport, Director, The Wellcome Trust
Contract Manufacturing
Dr Alan K Smith, President and Chief Operating Officer, Cognate BioServices
Dr Robert A Preti, President and Chief Scientific Officer, Progenitor Cell Therapy

Venture Capital
Greg A Bonfiglio, Managing Director, Partner, Proteus Venture Partners
Linda Powers, Managing Director and Co-Founder, Toucan Capital
Dr Werner Wolf, Venture Partner, TVM Capital
Michael D Goldberg, General Partner, Mohr, Davidow Ventures

Legal
Ivor Elrifi, Senior Partner, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
Julian Hitchcock, Senior Solicitor, Mills & Reeves
James Lawford Davies, Solicitor, Bevan-Brittan and University of Newcastle

 
Deadline for Abstracts: -
 
Registration: https://secure.terrapinn.com/v4/FRM_Del1.aspx?EID=1585
E-mail: julie.phillips@terrapinn.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.